Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids

Схожие документы

• EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
  по: FUDALA, P.J
• The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
  по: Middleton, L.S
• PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
  по: POTTER, J.S
• OPIOID DETOXIFICATION WITH BUPRENORPHINE, CLONIDINE, OR METHADONE IN HOSPITALIZED HEROIN-DEPENDENT PATIENTS WITH HIV INFECTION
  по: UMBRICHT, A.
• Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
  по: Rosenthal, R.N